News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 361–396
- Matches
- 14648
- Sources here
- 17
- Companies here
- 43
Search results
Stored financial headlines
Active search
14648 matching headlines
Ticker or company: LSMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Huntington Ingalls Industries Inc. stock underperforms Thursday when compared to competitors
Shares of Huntington Ingalls Industries Inc. (HII) fell by 3.32% on Thursday, closing at $301.40. This decline occurred during a broader market downturn, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This marks the fourth consecutive day of losses …
HII
main company
Sharemaestro market context
Price below Trend Line
52 weeks +23.5% · Next-week setup positive 57.1%
Applied Materials Delivered a Record Quarter. The Stock Fell Anyway
Applied Materials (AMAT) reported a record fiscal third quarter with revenue up 25% year-over-year and EPS up 41%, exceeding analyst expectations. Despite strong performance and an optimistic outlook driven by AI demand, the stock fell over 3% after-hours, likely due to its "priced for …
AMAT
main company
AMAT
main company
A1MT34
main company
AMAT
main company
AMAT
main company
AP2
main company
Sharemaestro market context
Trend signal active
52 weeks +267.8% · Next-week setup positive 62.8%
Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy
In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron's …
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4%Air Products (APD) Stock Looks Fully Priced Despite A 14% Fair Value Gap
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Air Products and Chemicals has delivered a 27.8% total return over the past five …
Sharemaestro market context Trend signal active 52 weeks +5.3%Regeneron (REGN) Stock Looks Undervalued On Expanded Cancer Collaboration News
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Regeneron Pharmaceuticals stock has delivered a 43.0% return over the past year, yet the …
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4%Mirum Pharmaceuticals(MIRM.US) Officer Sells US$4 Million in Common Stock
A Mirum Pharmaceuticals officer recently sold common stock valued at approximately $4 million. This transaction indicates a significant insider sale at the company.
MIRM
main company
Sharemaestro market context
Trend signal active
52 weeks +40.7% · Next-week setup positive 56.4%
What Does FLSmidth (CPSE:FLS) Gain From Its New Service Business Chief?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. FLSmidth (CPSE:FLS) has appointed Petri Virrankoski as President of its Service Business Line. Virrankoski brings experience in turnaround, growth, profitability and operational improvement …
Sharemaestro market context Price above Trend Line 52 weeks +22.8%Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
Amylyx Pharmaceuticals has announced the pricing of an upsized underwritten public offering of 14,090,000 shares of its common stock at $35.50 per share, aiming to raise $500.2 million before deductions. The company plans to use the net proceeds for pre-commercial activities for avexitide, research …
AMLX
main company
Sharemaestro market context
Trend signal active
52 weeks +132.6% · Next-week setup positive 55.7%
Form 144(Amend) | Aura Minerals(AUGO.US) Insider Proposes to Sell 4.68 Million in Common Stocks
An insider at Aura Minerals (AUGO.US) has proposed to sell 4.68 million common stocks, as indicated by a Form 144(Amend) filing. This type of filing suggests a planned sale of restricted or control securities. The proposed sale involves a significant number of shares, which …
AUGO
main company
Sharemaestro market context
Price above Trend Line
52 weeks +178.8% · Next-week setup positive 68.3%
Air Products And Chemicals (APD) Draws Fresh Analyst Interest, Is An 11% Discount Warranted?
Air Products and Chemicals (APD) is attracting renewed analyst interest due to strong recent earnings, despite ongoing concerns about high capital spending, project exit charges, and helium pricing. The stock is currently trading at an 11.4% discount to analyst targets and estimated intrinsic value, …
APD
main company
Sharemaestro market context
Trend signal active
52 weeks +5.3%
EXL (EXLS) Stock Looks Above Fair Value Despite Fair Earnings
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. ExlService Holdings has delivered a 54.3% gain over the past 5 years, yet its current checks suggest the stock is not a clear bargain and …
EXLS
main company
Sharemaestro market context
Price above Trend Line
52 weeks -21.0% · Next-week setup positive 58.9%
Telix Pharmaceuticals (ASX:TLX) Shares Rise Today as H1 Revenue Climbs 22% to US$477 Million
Telix Pharmaceuticals (ASX:TLX) saw its shares rise as it reported a 22% increase in H1 2026 revenue to US$477 million, with a gross margin of 55%. Adjusted EBITDA surged by 146% to US$52 million, and the company achieved a profit after tax of US$38 …
Sharemaestro market context Price above Trend Line 52 weeks +36.8%Is MP Materials (MP) Too Expensive After Its Sales Surge?
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. MP Materials stock has delivered a very strong 177.7% gain over the past three years, yet the current valuation checks lean more cautious, with the …
MP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -13.5%
Telix Pharmaceuticals delivers robust half-year earnings and pipeline progress
Telix Pharmaceuticals (ASX: TLX) reported robust half-year results, with revenue up 22% to US$477 million and adjusted EBITDA surging 146% to US$52 million. The company made significant progress in pipeline development, strategic collaborations, and global manufacturing expansion. Telix reaffirmed its FY26 revenue guidance of …
REGN
main company
Sharemaestro market context
Price above Trend Line
52 weeks +36.8%
Why Park Hotels & Resorts (PK) Is Up 6.6% After Returning To Profitability In Q2 2026
Park Hotels & Resorts (PK) has returned to profitability in Q2 2026, reporting US$47 million in net income and positive EPS, a significant improvement from previous losses. Despite largely flat revenue, the company's focus on margin execution and shareholder returns, alongside a reiterated dividend …
PK
main company
Sharemaestro market context
Trend signal active
52 weeks +37.0% · Next-week setup negative 43.5%